Global Targeted Protein Degradation Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Targeted Protein Degradation Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Targeted Protein Degradation Drug industry chain, the market status of Cancer (PROTAC, Molecular Glue), Autoimmune Diseases (PROTAC, Molecular Glue), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Protein Degradation Drug.
Regionally, the report analyzes the Targeted Protein Degradation Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Protein Degradation Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Protein Degradation Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Protein Degradation Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PROTAC, Molecular Glue).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Protein Degradation Drug market.
Regional Analysis: The report involves examining the Targeted Protein Degradation Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Protein Degradation Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Protein Degradation Drug:
Company Analysis: Report covers individual Targeted Protein Degradation Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Protein Degradation Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Autoimmune Diseases).
Technology Analysis: Report covers specific technologies relevant to Targeted Protein Degradation Drug. It assesses the current state, advancements, and potential future developments in Targeted Protein Degradation Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Protein Degradation Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted Protein Degradation Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Targeted Protein Degradation Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Protein Degradation Drug, with revenue, gross margin and global market share of Targeted Protein Degradation Drug from 2019 to 2024.
Chapter 3, the Targeted Protein Degradation Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Targeted Protein Degradation Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Protein Degradation Drug.
Chapter 13, to describe Targeted Protein Degradation Drug research findings and conclusion.
The Global Info Research report includes an overview of the development of the Targeted Protein Degradation Drug industry chain, the market status of Cancer (PROTAC, Molecular Glue), Autoimmune Diseases (PROTAC, Molecular Glue), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Protein Degradation Drug.
Regionally, the report analyzes the Targeted Protein Degradation Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Protein Degradation Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Protein Degradation Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Protein Degradation Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PROTAC, Molecular Glue).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Protein Degradation Drug market.
Regional Analysis: The report involves examining the Targeted Protein Degradation Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Protein Degradation Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Protein Degradation Drug:
Company Analysis: Report covers individual Targeted Protein Degradation Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Protein Degradation Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Autoimmune Diseases).
Technology Analysis: Report covers specific technologies relevant to Targeted Protein Degradation Drug. It assesses the current state, advancements, and potential future developments in Targeted Protein Degradation Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Protein Degradation Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted Protein Degradation Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- PROTAC
- Molecular Glue
- Cancer
- Autoimmune Diseases
- Other
- Arvinas
- Kangpu Biopharmaceuticals
- Ranok Therapeutics
- Accutar Biotechnology
- BeiGene Ltd.
- Hinova Pharmaceuticals
- Haisco Pharmaceutical
- Nurix
- Kymera Therapeutics
- C4 Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Targeted Protein Degradation Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Protein Degradation Drug, with revenue, gross margin and global market share of Targeted Protein Degradation Drug from 2019 to 2024.
Chapter 3, the Targeted Protein Degradation Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Targeted Protein Degradation Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Protein Degradation Drug.
Chapter 13, to describe Targeted Protein Degradation Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Targeted Protein Degradation Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Targeted Protein Degradation Drug by Type
1.3.1 Overview: Global Targeted Protein Degradation Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Targeted Protein Degradation Drug Consumption Value Market Share by Type in 2023
1.3.3 PROTAC
1.3.4 Molecular Glue
1.4 Global Targeted Protein Degradation Drug Market by Application
1.4.1 Overview: Global Targeted Protein Degradation Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Autoimmune Diseases
1.4.4 Other
1.5 Global Targeted Protein Degradation Drug Market Size & Forecast
1.6 Global Targeted Protein Degradation Drug Market Size and Forecast by Region
1.6.1 Global Targeted Protein Degradation Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Targeted Protein Degradation Drug Market Size by Region, (2019-2030)
1.6.3 North America Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.4 Europe Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.6 South America Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Arvinas
2.1.1 Arvinas Details
2.1.2 Arvinas Major Business
2.1.3 Arvinas Targeted Protein Degradation Drug Product and Solutions
2.1.4 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Arvinas Recent Developments and Future Plans
2.2 Kangpu Biopharmaceuticals
2.2.1 Kangpu Biopharmaceuticals Details
2.2.2 Kangpu Biopharmaceuticals Major Business
2.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Solutions
2.2.4 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Kangpu Biopharmaceuticals Recent Developments and Future Plans
2.3 Ranok Therapeutics
2.3.1 Ranok Therapeutics Details
2.3.2 Ranok Therapeutics Major Business
2.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Product and Solutions
2.3.4 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Ranok Therapeutics Recent Developments and Future Plans
2.4 Accutar Biotechnology
2.4.1 Accutar Biotechnology Details
2.4.2 Accutar Biotechnology Major Business
2.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Product and Solutions
2.4.4 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Accutar Biotechnology Recent Developments and Future Plans
2.5 BeiGene Ltd.
2.5.1 BeiGene Ltd. Details
2.5.2 BeiGene Ltd. Major Business
2.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Product and Solutions
2.5.4 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BeiGene Ltd. Recent Developments and Future Plans
2.6 Hinova Pharmaceuticals
2.6.1 Hinova Pharmaceuticals Details
2.6.2 Hinova Pharmaceuticals Major Business
2.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Solutions
2.6.4 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hinova Pharmaceuticals Recent Developments and Future Plans
2.7 Haisco Pharmaceutical
2.7.1 Haisco Pharmaceutical Details
2.7.2 Haisco Pharmaceutical Major Business
2.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Solutions
2.7.4 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Haisco Pharmaceutical Recent Developments and Future Plans
2.8 Nurix
2.8.1 Nurix Details
2.8.2 Nurix Major Business
2.8.3 Nurix Targeted Protein Degradation Drug Product and Solutions
2.8.4 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Nurix Recent Developments and Future Plans
2.9 Kymera Therapeutics
2.9.1 Kymera Therapeutics Details
2.9.2 Kymera Therapeutics Major Business
2.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Product and Solutions
2.9.4 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kymera Therapeutics Recent Developments and Future Plans
2.10 C4 Therapeutics
2.10.1 C4 Therapeutics Details
2.10.2 C4 Therapeutics Major Business
2.10.3 C4 Therapeutics Targeted Protein Degradation Drug Product and Solutions
2.10.4 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 C4 Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Targeted Protein Degradation Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Targeted Protein Degradation Drug by Company Revenue
3.2.2 Top 3 Targeted Protein Degradation Drug Players Market Share in 2023
3.2.3 Top 6 Targeted Protein Degradation Drug Players Market Share in 2023
3.3 Targeted Protein Degradation Drug Market: Overall Company Footprint Analysis
3.3.1 Targeted Protein Degradation Drug Market: Region Footprint
3.3.2 Targeted Protein Degradation Drug Market: Company Product Type Footprint
3.3.3 Targeted Protein Degradation Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Targeted Protein Degradation Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global Targeted Protein Degradation Drug Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global Targeted Protein Degradation Drug Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
6.2 North America Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
6.3 North America Targeted Protein Degradation Drug Market Size by Country
6.3.1 North America Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
6.3.2 United States Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
6.3.3 Canada Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
7.2 Europe Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
7.3 Europe Targeted Protein Degradation Drug Market Size by Country
7.3.1 Europe Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
7.3.2 Germany Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.3 France Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.5 Russia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.6 Italy Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region
8.3.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2019-2030)
8.3.2 China Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.3 Japan Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.5 India Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.7 Australia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
9.2 South America Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
9.3 South America Targeted Protein Degradation Drug Market Size by Country
9.3.1 South America Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country
10.3.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10.3.4 UAE Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Targeted Protein Degradation Drug Market Drivers
11.2 Targeted Protein Degradation Drug Market Restraints
11.3 Targeted Protein Degradation Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Targeted Protein Degradation Drug Industry Chain
12.2 Targeted Protein Degradation Drug Upstream Analysis
12.3 Targeted Protein Degradation Drug Midstream Analysis
12.4 Targeted Protein Degradation Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Targeted Protein Degradation Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Targeted Protein Degradation Drug by Type
1.3.1 Overview: Global Targeted Protein Degradation Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Targeted Protein Degradation Drug Consumption Value Market Share by Type in 2023
1.3.3 PROTAC
1.3.4 Molecular Glue
1.4 Global Targeted Protein Degradation Drug Market by Application
1.4.1 Overview: Global Targeted Protein Degradation Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Autoimmune Diseases
1.4.4 Other
1.5 Global Targeted Protein Degradation Drug Market Size & Forecast
1.6 Global Targeted Protein Degradation Drug Market Size and Forecast by Region
1.6.1 Global Targeted Protein Degradation Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Targeted Protein Degradation Drug Market Size by Region, (2019-2030)
1.6.3 North America Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.4 Europe Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.6 South America Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Arvinas
2.1.1 Arvinas Details
2.1.2 Arvinas Major Business
2.1.3 Arvinas Targeted Protein Degradation Drug Product and Solutions
2.1.4 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Arvinas Recent Developments and Future Plans
2.2 Kangpu Biopharmaceuticals
2.2.1 Kangpu Biopharmaceuticals Details
2.2.2 Kangpu Biopharmaceuticals Major Business
2.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Solutions
2.2.4 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Kangpu Biopharmaceuticals Recent Developments and Future Plans
2.3 Ranok Therapeutics
2.3.1 Ranok Therapeutics Details
2.3.2 Ranok Therapeutics Major Business
2.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Product and Solutions
2.3.4 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Ranok Therapeutics Recent Developments and Future Plans
2.4 Accutar Biotechnology
2.4.1 Accutar Biotechnology Details
2.4.2 Accutar Biotechnology Major Business
2.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Product and Solutions
2.4.4 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Accutar Biotechnology Recent Developments and Future Plans
2.5 BeiGene Ltd.
2.5.1 BeiGene Ltd. Details
2.5.2 BeiGene Ltd. Major Business
2.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Product and Solutions
2.5.4 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BeiGene Ltd. Recent Developments and Future Plans
2.6 Hinova Pharmaceuticals
2.6.1 Hinova Pharmaceuticals Details
2.6.2 Hinova Pharmaceuticals Major Business
2.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Solutions
2.6.4 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hinova Pharmaceuticals Recent Developments and Future Plans
2.7 Haisco Pharmaceutical
2.7.1 Haisco Pharmaceutical Details
2.7.2 Haisco Pharmaceutical Major Business
2.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Solutions
2.7.4 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Haisco Pharmaceutical Recent Developments and Future Plans
2.8 Nurix
2.8.1 Nurix Details
2.8.2 Nurix Major Business
2.8.3 Nurix Targeted Protein Degradation Drug Product and Solutions
2.8.4 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Nurix Recent Developments and Future Plans
2.9 Kymera Therapeutics
2.9.1 Kymera Therapeutics Details
2.9.2 Kymera Therapeutics Major Business
2.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Product and Solutions
2.9.4 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kymera Therapeutics Recent Developments and Future Plans
2.10 C4 Therapeutics
2.10.1 C4 Therapeutics Details
2.10.2 C4 Therapeutics Major Business
2.10.3 C4 Therapeutics Targeted Protein Degradation Drug Product and Solutions
2.10.4 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 C4 Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Targeted Protein Degradation Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Targeted Protein Degradation Drug by Company Revenue
3.2.2 Top 3 Targeted Protein Degradation Drug Players Market Share in 2023
3.2.3 Top 6 Targeted Protein Degradation Drug Players Market Share in 2023
3.3 Targeted Protein Degradation Drug Market: Overall Company Footprint Analysis
3.3.1 Targeted Protein Degradation Drug Market: Region Footprint
3.3.2 Targeted Protein Degradation Drug Market: Company Product Type Footprint
3.3.3 Targeted Protein Degradation Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Targeted Protein Degradation Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global Targeted Protein Degradation Drug Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global Targeted Protein Degradation Drug Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
6.2 North America Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
6.3 North America Targeted Protein Degradation Drug Market Size by Country
6.3.1 North America Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
6.3.2 United States Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
6.3.3 Canada Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
7.2 Europe Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
7.3 Europe Targeted Protein Degradation Drug Market Size by Country
7.3.1 Europe Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
7.3.2 Germany Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.3 France Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.5 Russia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7.3.6 Italy Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region
8.3.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2019-2030)
8.3.2 China Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.3 Japan Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.5 India Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8.3.7 Australia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
9.2 South America Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
9.3 South America Targeted Protein Degradation Drug Market Size by Country
9.3.1 South America Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country
10.3.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10.3.4 UAE Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Targeted Protein Degradation Drug Market Drivers
11.2 Targeted Protein Degradation Drug Market Restraints
11.3 Targeted Protein Degradation Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Targeted Protein Degradation Drug Industry Chain
12.2 Targeted Protein Degradation Drug Upstream Analysis
12.3 Targeted Protein Degradation Drug Midstream Analysis
12.4 Targeted Protein Degradation Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Targeted Protein Degradation Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Targeted Protein Degradation Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Targeted Protein Degradation Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Targeted Protein Degradation Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Arvinas Company Information, Head Office, and Major Competitors
Table 6. Arvinas Major Business
Table 7. Arvinas Targeted Protein Degradation Drug Product and Solutions
Table 8. Arvinas Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Arvinas Recent Developments and Future Plans
Table 10. Kangpu Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Kangpu Biopharmaceuticals Major Business
Table 12. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Solutions
Table 13. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Kangpu Biopharmaceuticals Recent Developments and Future Plans
Table 15. Ranok Therapeutics Company Information, Head Office, and Major Competitors
Table 16. Ranok Therapeutics Major Business
Table 17. Ranok Therapeutics Targeted Protein Degradation Drug Product and Solutions
Table 18. Ranok Therapeutics Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Ranok Therapeutics Recent Developments and Future Plans
Table 20. Accutar Biotechnology Company Information, Head Office, and Major Competitors
Table 21. Accutar Biotechnology Major Business
Table 22. Accutar Biotechnology Targeted Protein Degradation Drug Product and Solutions
Table 23. Accutar Biotechnology Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Accutar Biotechnology Recent Developments and Future Plans
Table 25. BeiGene Ltd. Company Information, Head Office, and Major Competitors
Table 26. BeiGene Ltd. Major Business
Table 27. BeiGene Ltd. Targeted Protein Degradation Drug Product and Solutions
Table 28. BeiGene Ltd. Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BeiGene Ltd. Recent Developments and Future Plans
Table 30. Hinova Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Hinova Pharmaceuticals Major Business
Table 32. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Solutions
Table 33. Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Hinova Pharmaceuticals Recent Developments and Future Plans
Table 35. Haisco Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Haisco Pharmaceutical Major Business
Table 37. Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Solutions
Table 38. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Haisco Pharmaceutical Recent Developments and Future Plans
Table 40. Nurix Company Information, Head Office, and Major Competitors
Table 41. Nurix Major Business
Table 42. Nurix Targeted Protein Degradation Drug Product and Solutions
Table 43. Nurix Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Nurix Recent Developments and Future Plans
Table 45. Kymera Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Kymera Therapeutics Major Business
Table 47. Kymera Therapeutics Targeted Protein Degradation Drug Product and Solutions
Table 48. Kymera Therapeutics Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Kymera Therapeutics Recent Developments and Future Plans
Table 50. C4 Therapeutics Company Information, Head Office, and Major Competitors
Table 51. C4 Therapeutics Major Business
Table 52. C4 Therapeutics Targeted Protein Degradation Drug Product and Solutions
Table 53. C4 Therapeutics Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. C4 Therapeutics Recent Developments and Future Plans
Table 55. Global Targeted Protein Degradation Drug Revenue (USD Million) by Players (2019-2024)
Table 56. Global Targeted Protein Degradation Drug Revenue Share by Players (2019-2024)
Table 57. Breakdown of Targeted Protein Degradation Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Targeted Protein Degradation Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Targeted Protein Degradation Drug Players
Table 60. Targeted Protein Degradation Drug Market: Company Product Type Footprint
Table 61. Targeted Protein Degradation Drug Market: Company Product Application Footprint
Table 62. Targeted Protein Degradation Drug New Market Entrants and Barriers to Market Entry
Table 63. Targeted Protein Degradation Drug Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Targeted Protein Degradation Drug Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Targeted Protein Degradation Drug Consumption Value Share by Type (2019-2024)
Table 66. Global Targeted Protein Degradation Drug Consumption Value Forecast by Type (2025-2030)
Table 67. Global Targeted Protein Degradation Drug Consumption Value by Application (2019-2024)
Table 68. Global Targeted Protein Degradation Drug Consumption Value Forecast by Application (2025-2030)
Table 69. North America Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Targeted Protein Degradation Drug Raw Material
Table 100. Key Suppliers of Targeted Protein Degradation Drug Raw Materials
Table 1. Global Targeted Protein Degradation Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Targeted Protein Degradation Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Targeted Protein Degradation Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Targeted Protein Degradation Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Arvinas Company Information, Head Office, and Major Competitors
Table 6. Arvinas Major Business
Table 7. Arvinas Targeted Protein Degradation Drug Product and Solutions
Table 8. Arvinas Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Arvinas Recent Developments and Future Plans
Table 10. Kangpu Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Kangpu Biopharmaceuticals Major Business
Table 12. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Solutions
Table 13. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Kangpu Biopharmaceuticals Recent Developments and Future Plans
Table 15. Ranok Therapeutics Company Information, Head Office, and Major Competitors
Table 16. Ranok Therapeutics Major Business
Table 17. Ranok Therapeutics Targeted Protein Degradation Drug Product and Solutions
Table 18. Ranok Therapeutics Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Ranok Therapeutics Recent Developments and Future Plans
Table 20. Accutar Biotechnology Company Information, Head Office, and Major Competitors
Table 21. Accutar Biotechnology Major Business
Table 22. Accutar Biotechnology Targeted Protein Degradation Drug Product and Solutions
Table 23. Accutar Biotechnology Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Accutar Biotechnology Recent Developments and Future Plans
Table 25. BeiGene Ltd. Company Information, Head Office, and Major Competitors
Table 26. BeiGene Ltd. Major Business
Table 27. BeiGene Ltd. Targeted Protein Degradation Drug Product and Solutions
Table 28. BeiGene Ltd. Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BeiGene Ltd. Recent Developments and Future Plans
Table 30. Hinova Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Hinova Pharmaceuticals Major Business
Table 32. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Solutions
Table 33. Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Hinova Pharmaceuticals Recent Developments and Future Plans
Table 35. Haisco Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Haisco Pharmaceutical Major Business
Table 37. Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Solutions
Table 38. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Haisco Pharmaceutical Recent Developments and Future Plans
Table 40. Nurix Company Information, Head Office, and Major Competitors
Table 41. Nurix Major Business
Table 42. Nurix Targeted Protein Degradation Drug Product and Solutions
Table 43. Nurix Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Nurix Recent Developments and Future Plans
Table 45. Kymera Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Kymera Therapeutics Major Business
Table 47. Kymera Therapeutics Targeted Protein Degradation Drug Product and Solutions
Table 48. Kymera Therapeutics Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Kymera Therapeutics Recent Developments and Future Plans
Table 50. C4 Therapeutics Company Information, Head Office, and Major Competitors
Table 51. C4 Therapeutics Major Business
Table 52. C4 Therapeutics Targeted Protein Degradation Drug Product and Solutions
Table 53. C4 Therapeutics Targeted Protein Degradation Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. C4 Therapeutics Recent Developments and Future Plans
Table 55. Global Targeted Protein Degradation Drug Revenue (USD Million) by Players (2019-2024)
Table 56. Global Targeted Protein Degradation Drug Revenue Share by Players (2019-2024)
Table 57. Breakdown of Targeted Protein Degradation Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Targeted Protein Degradation Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Targeted Protein Degradation Drug Players
Table 60. Targeted Protein Degradation Drug Market: Company Product Type Footprint
Table 61. Targeted Protein Degradation Drug Market: Company Product Application Footprint
Table 62. Targeted Protein Degradation Drug New Market Entrants and Barriers to Market Entry
Table 63. Targeted Protein Degradation Drug Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Targeted Protein Degradation Drug Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Targeted Protein Degradation Drug Consumption Value Share by Type (2019-2024)
Table 66. Global Targeted Protein Degradation Drug Consumption Value Forecast by Type (2025-2030)
Table 67. Global Targeted Protein Degradation Drug Consumption Value by Application (2019-2024)
Table 68. Global Targeted Protein Degradation Drug Consumption Value Forecast by Application (2025-2030)
Table 69. North America Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Targeted Protein Degradation Drug Raw Material
Table 100. Key Suppliers of Targeted Protein Degradation Drug Raw Materials
LIST OF FIGURES
Figure 1. Targeted Protein Degradation Drug Picture
Figure 2. Global Targeted Protein Degradation Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Targeted Protein Degradation Drug Consumption Value Market Share by Type in 2023
Figure 4. PROTAC
Figure 5. Molecular Glue
Figure 6. Global Targeted Protein Degradation Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Targeted Protein Degradation Drug Consumption Value Market Share by Application in 2023
Figure 8. Cancer Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Other Picture
Figure 11. Global Targeted Protein Degradation Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Targeted Protein Degradation Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Targeted Protein Degradation Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Targeted Protein Degradation Drug Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Targeted Protein Degradation Drug Consumption Value Market Share by Region in 2023
Figure 16. North America Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Targeted Protein Degradation Drug Revenue Share by Players in 2023
Figure 22. Targeted Protein Degradation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Targeted Protein Degradation Drug Market Share in 2023
Figure 24. Global Top 6 Players Targeted Protein Degradation Drug Market Share in 2023
Figure 25. Global Targeted Protein Degradation Drug Consumption Value Share by Type (2019-2024)
Figure 26. Global Targeted Protein Degradation Drug Market Share Forecast by Type (2025-2030)
Figure 27. Global Targeted Protein Degradation Drug Consumption Value Share by Application (2019-2024)
Figure 28. Global Targeted Protein Degradation Drug Market Share Forecast by Application (2025-2030)
Figure 29. North America Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. France Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Targeted Protein Degradation Drug Consumption Value Market Share by Region (2019-2030)
Figure 46. China Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. India Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. Targeted Protein Degradation Drug Market Drivers
Figure 64. Targeted Protein Degradation Drug Market Restraints
Figure 65. Targeted Protein Degradation Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Targeted Protein Degradation Drug in 2023
Figure 68. Manufacturing Process Analysis of Targeted Protein Degradation Drug
Figure 69. Targeted Protein Degradation Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Targeted Protein Degradation Drug Picture
Figure 2. Global Targeted Protein Degradation Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Targeted Protein Degradation Drug Consumption Value Market Share by Type in 2023
Figure 4. PROTAC
Figure 5. Molecular Glue
Figure 6. Global Targeted Protein Degradation Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Targeted Protein Degradation Drug Consumption Value Market Share by Application in 2023
Figure 8. Cancer Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Other Picture
Figure 11. Global Targeted Protein Degradation Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Targeted Protein Degradation Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Targeted Protein Degradation Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Targeted Protein Degradation Drug Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Targeted Protein Degradation Drug Consumption Value Market Share by Region in 2023
Figure 16. North America Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Targeted Protein Degradation Drug Revenue Share by Players in 2023
Figure 22. Targeted Protein Degradation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Targeted Protein Degradation Drug Market Share in 2023
Figure 24. Global Top 6 Players Targeted Protein Degradation Drug Market Share in 2023
Figure 25. Global Targeted Protein Degradation Drug Consumption Value Share by Type (2019-2024)
Figure 26. Global Targeted Protein Degradation Drug Market Share Forecast by Type (2025-2030)
Figure 27. Global Targeted Protein Degradation Drug Consumption Value Share by Application (2019-2024)
Figure 28. Global Targeted Protein Degradation Drug Market Share Forecast by Application (2025-2030)
Figure 29. North America Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. France Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Targeted Protein Degradation Drug Consumption Value Market Share by Region (2019-2030)
Figure 46. China Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. India Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Targeted Protein Degradation Drug Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Targeted Protein Degradation Drug Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. Targeted Protein Degradation Drug Market Drivers
Figure 64. Targeted Protein Degradation Drug Market Restraints
Figure 65. Targeted Protein Degradation Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Targeted Protein Degradation Drug in 2023
Figure 68. Manufacturing Process Analysis of Targeted Protein Degradation Drug
Figure 69. Targeted Protein Degradation Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
